Section Arrow
BGLC.NASDAQ
- Bionexus Gene Lab Corp
Quotes are at least 15-min delayed:2026/09/26 18:22 EDT
Regular Hours
Last
 1.39
-0.09 (-6.08%)
Day High 
1.4699 
Prev. Close
1.48 
1-M High
1.61 
Volume 
6.04K 
Bid
1.3
Ask
1.39
Day Low
1.2534 
Open
1.43 
1-M Low
1.24 
Market Cap 
4.34M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.5 
20-SMA 1.48 
50-SMA 1.52 
52-W High 5.8876 
52-W Low 1.07 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.26/--
Enterprise Value
4.46M
Balance Sheet
Book Value Per Share
2.65
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.42M
Operating Revenue Per Share
3.53
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ESIElement Solutions35.71+1.21+3.51%46.62PE
ASPIASP Isotopes2.925-0.025-0.85%-- 
LYBLyondellBasell Industries NV58.14-2.04-3.39%-- 
LWLGLightwave Logic5.31+0.03+0.57%-- 
GEVOGevo1.4------ 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.